Medical Research, Diagnostic Substances & Life Science Tools Report

Wall Street Transcript
October 17, 2011
26 Pages - SKU: WST6631657
License type:
The Wall Street Transcript has just published its Medical Research, Diagnostic Substances & Life Science Tools Report, a report offering a timely review of the sector to serious investors and industry executives. This 26-page feature contains industry commentary through in-depth interviews with 4 leading Analysts; and top management from 3 Sector Firms. Topics covered: Health Care Consolidation Activity - Volatility Along the Market-Cap Spectrum - Hospital Capital Spending and Utilization Rates - Cost Reduction Amid Reimbursement Uncertainty